Dr. Schechter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1717 W Woolbright Rd
Boynton Beach, FL 33426Phone+1 561-737-5500Fax+1 561-737-7055- Is this information wrong?
Education & Training
University of Texas Health Science Center at HoustonResidency, Ophthalmology, 1992 - 1993
SUNY Health Science Center at BrooklynResidency, Ophthalmology, 1989 - 1992
Icahn School of Medicine at Mount Sinai (Beth Israel)Internship, Internal Medicine, 1988 - 1989
State University of New York Downstate Medical Center College of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 1992 - 2026
TX State Medical License 1992 - 1993- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
- Top MD Consumers Checkbook
Clinical Trials
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
- Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase Start of enrollment: 2007 Aug 01
- Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality Start of enrollment: 2008 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOptimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review.Barry Schechter, Francis Mah> ;Ophthalmology and Therapy. 2022 Jun 1
- Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina, Brittany Mitchell, Jodi I Luchs> ;Clinical Ophthalmology. 2022 Jan 1
- 5 citationsPhase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.John D. Sheppard, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, Abayomi Ogundele, Paul M. Karpecki> ;Clinical Ophthalmology. 2021 Jan 12
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Bethesda Hospital EastBoynton Beach, Florida- St. Mary's Medical CenterWest Palm Beach, Florida
- Wellington Regional Medical CenterWellington, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
